AVOQ, LLC for PFIZER, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 22, 2024 | $50,000 | Replaced |
| 1st Quarter - Amendment | Sep 17, 2024 | $50,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General health issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SANDRA ALCALA | — |
| STEVEN ELMENDORF | — |
| BILL GHENT | — |
Trade (domestic/foreign) TRD
Issues related to a Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver for COVID-19 therapeutics
| Lobbyist | Covered position, as disclosed |
|---|---|
| SANDRA ALCALA | — |
| STEVEN ELMENDORF | — |
| BILL GHENT | — |
Taxation/Internal Revenue Code TAX
Issues related to the Vaccine Injury Compensation Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL GHENT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.